Market Tracker

04/29 6:45pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

7.08
Delayed Data
As of Apr 29
 -0.21 / -2.88%
Today’s Change
5.02
Today|||52-Week Range
13.26
-10.38%
Year-to-Date

Today’s Trading

Previous close7.29
Today’s open7.10
Day’s range7.06 - 7.40
Volume1,189,363
Average volume (3 months)1,842,188
Market cap$915.2M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-0.33-1.22%
ADROAduro Biotech Inc-0.68-4.99%
TBPHTheravance Biopharma...-0.41-1.94%
CLLSCellectis SA-0.44-1.59%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 2, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts